Insights
WHAT CYNAERA SEES THAT OTHERS MISS
We don’t just collect data. We decode the patterns shaping global systems.
CYNAERA is the intelligence backbone for the 21st century. By fusing real-time signals from social media, environmental sensors, testimonials, and digital records, our platform spots hidden risks, untapped demand, and silent disruptions before traditional systems even blink.
We bridge structured datasets with human behavior, climate signals, public sentiment, and operational noise, delivering a panoramic view of systemic shifts. It’s not just analytics. It’s visibility.
1000 + core modules. 180+ countries. 32+ industries.
KEY CAPABILITIES
Real-Time Population Mapping
S³ Model™ pulls from public social media signals to estimate true activity, interest, and need from health to migration to education.
Signal-Based Risk Detection
RAEMI™, and PULSE™ modules expose where disruptions are forming, whether in water systems, disease trends, school absences, or infrastructure failure.
Environmental Risk Forecasting
VitalGuard™ can map mold risk, air toxicity, wildfire exposure, and climate pressure, including for zones where traditional monitoring fails.
System Monitoring for Large Institutions
EASE™, RePath™, and BRAG™ modules flag failure patterns in hospital systems, insurance, education, law enforcement, and supply chains.
CLINICAL TRIAL TERRAIN SAFETY ANALYSIS
CYNAERA has developed terrain safety frameworks to identify destabilization risks in multi-system post-viral and autoimmune cohorts. An example application includes a Tirzepatide Terrain Safety & Stability model, designed to prevent avoidable adverse events in Long COVID and ME/CFS populations by integrating autonomic, environmental, and physiologic readiness signals into dosing decisions.
The model incorporates heart-rate variability, sleep stability, air quality, humidity, blood pressure variability, and exertion trends to generate a Terrain Readiness Score. This approach demonstrates how environmental load and autonomic instability can alter drug tolerance, trial retention, and outcome reliability in complex chronic illness cohorts.
This and similar analyses illustrate systemic gaps in conventional trial design, where physiologic instability and environmental exposures are rarely modeled despite their impact on safety, adherence, and data integrity.
DYNAMIC LICENSING
CYNAERA Market supports adaptive module expansion, allowing partners to submit specifications for new analytical modules that are mapped into CYNAERA’s core terrain frameworks (including BST™ and related engines). This enables horizontal scaling across conditions, research domains, and policy use cases with minimal incremental engineering.
ON-DEMAND EXPANSION
Partners can request modules not yet listed on the Market (clinical, environmental, operational, or socio-economic). CYNAERA builds, integrates, and licenses these modules within the same backbone.
REVENUE ELASTICITY
Module expansion creates billable integration and licensing events that can materially increase average revenue per customer beyond standard plans.
PARTNER-DRIVEN R&D PIPELINE
University, nonprofit, and institutional projects can be translated into reusable modules that strengthen the ecosystem while preserving CYNAERA’s governance and IP boundaries.
INSTANT CROSS-SECTOR FIT
A hospital, climate-risk lab, and policy institute can run sector-specific overlays on the same terrain backbone, enabling coordinated use without rebuilding systems.
PREVALENCE-ADJUSTED DATABASE
Official statistics routinely underestimate chronic and infection-associated conditions due to misdiagnosis, outdated coding, underreporting, and barriers to care. CYNAERA’s Prevalence-Adjusted Database corrects these distortions to produce more accurate burden estimates across conditions including ME/CFS, Long COVID, autoimmune diseases, dysautonomia, and select cancers linked to immune dysfunction. This is not a static dataset. It is a continuously updated intelligence layer that integrates clinical records, environmental exposures, symptom trajectories, and population-level signals to reveal the true scale and distribution of disease.
WHY IT MATTERS
When conditions are invisible in official data, they are invisible in budgets, research priorities, and infrastructure planning. Prevalence correction enables:• Accurate funding and policy decisions
• Realistic workforce and disability projections
• Stronger clinical trial design and recruitment feasibility
• Evidence-backed advocacy and legislative briefing
• Clearer market sizing for therapeutics and diagnostics
STRATEGIC VALUE
Used across multiple disease domains, the database provides a corrected denominator for decision-making in government, research, healthcare, and industry.
GLOBAL IMPACT
Metric Value
Illnesses Modeled 2,000+
Core AI Frameworks 1000+
Dynamic AI Modules 5 Billion +
Synthetic Patient Journeys 1 Billion +
White Papers Published 50+ since April 2025
Pilot Programs 2 active, cross-sector reach
Projected U.S. Reach 99% of the population
Global Reach All major COVID infrastructures
Based on global prevalence of terrain-sensitive, relapsing, and environment-reactive conditions, CYNAERA’s remission and flare forecasting system is applicable to an estimated 3 to 4 billion people worldwide, spanning chronic illness, autoimmune disease, post-infectious syndromes, respiratory conditions, and climate-sensitive health vulnerabilities.